🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tal Sella

Harvard University

ORCID: 0000-0003-2030-9200

Also affiliated with Tel Aviv University, Sheba Medical Center, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer”.

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-23-1711
N/A
0.596DataRank · unranked
15 citations

Yingtian Xie, Shira Sherman, Zsuzsanna Nagy, Douglas Russo, Tara Akhshi +36 more

Clonal Hematopoiesis in Young Women Treated for Breast Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0050
N/A
0.505DataRank · unranked
28 citations

Geoffrey Fell, Tal Sella, Adam S. Sperling, Craig Snow, Shoshana M. Rosenberg +8 more

Effects of an educational physical activity intervention in young women with newly diagnosed breast cancer: Findings from the Young and Strong Study

Cancer(2023)10.1002/cncr.34779
N/A
0DataRank · unranked
4 citations

Yue Zheng, William T. Barry, Tal Sella, Kathryn J. Ruddy, Mary L. Greaney +4 more